KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $128000.0.

  • TherapeuticsMD's Other Operating Expenses rose 3333.33% to $128000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $514000.0, marking a year-over-year decrease of 7937.4%. This contributed to the annual value of $1.8 million for FY2024, which is 11618.0% up from last year.
  • TherapeuticsMD's Other Operating Expenses amounted to $128000.0 in Q3 2025, which was up 3333.33% from $96000.0 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Other Operating Expenses registered a high of $143.4 million during Q2 2022, and its lowest value of -$93.3 million during Q4 2021.
  • Its 5-year average for Other Operating Expenses is $9.9 million, with a median of $183000.0 in 2025.
  • In the last 5 years, TherapeuticsMD's Other Operating Expenses crashed by 45882.06% in 2021 and then surged by 34579.03% in 2022.
  • TherapeuticsMD's Other Operating Expenses (Quarter) stood at -$93.3 million in 2021, then skyrocketed by 110.79% to $10.1 million in 2022, then plummeted by 91.83% to $822000.0 in 2023, then crashed by 86.98% to $107000.0 in 2024, then rose by 19.63% to $128000.0 in 2025.
  • Its last three reported values are $128000.0 in Q3 2025, $96000.0 for Q2 2025, and $183000.0 during Q1 2025.